Motoaki Saito

7PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 17, 2026
Changes and clinical impact of HER3 and ERBB3 expression in primary and recurrent ovarian cancer.

|Jul 25, 2026
Outcome of advanced ovarian cancer patients who do not undergo cytoreductive surgery in the era of PARP inhibitors maintenance therapy: a propensity score-based analysis.

|Nov 07, 2025
Molecular and pathological analysis of FOXL2 and TERT promoter mutations in adult-type granulosa cell tumors of the ovary: a study of 64 Japanese patients.

Satoshi Yanagida, Yuichi Shoburu, Takako Kiyokawa

|Apr 05, 2024
A retrospective study of dose-dense paclitaxel and carboplatin plus bevacizumab as first-line treatment of advanced epithelial ovarian cancer.

Hiromi Komazaki, Kazuaki Takahashi, Hiroshi Tanabe

|Jan 18, 2023
Evaluation of non-hematologic toxicity in patients with cervical cancer after Type 3 radical hysterectomy followed by concurrent chemoradiotherapy: a retrospective study.

Motoaki Saito, Hiroshi Tanabe, Kishihito Yamauchi

|Jun 17, 2022
Efficacy of edoxaban for the treatment of gynecological cancer-associated venous thromboembolism: analysis of Japanese real-world data.

Suguru Odajima, Toshiyuki Seki, Sayako Kato

Pageof 2

Frequent Collaborators

6 joint publications

Hirokuni Takano

5 joint publications

Kyosuke Yamada

5 joint publications

Aikou Okamoto

3 joint publications

Hiroshi Tanabe